The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App 
Professionals >> Visit The Body PROThe Body en Espanol

HIV Life >> Living With HIV

Pages: 1
New User

Reged: 07/12/00
Posts: 15
Clinical Trials Opportunities
      #9711 - 09/17/00 01:53 PM


We are trying to get HIV Groups & Organizations, Medical and Pharmaceutical Institutions, and Universities and the Medical & Scientific Communities aware, informed and interested in MM-1, so that they can consider and help to Sponsor the MM-1 Clinical Trials, in order to assist those Persons with HIV/AIDS to obtain the MM-1 HIV/AIDS Treatment FREE of CHARGE, IF they qualify and are in the sponsored MM-1 Clinical Trials Study?

MM-1 is the alternative, natural, safe and effective treatment for HIV/AIDS, used Internationally, since 1987 on over 10,000 patients. The Pre-Clinical and Clinical Trials Summary Results for MM-1 from 1987-1993 have been done by The Inventor and Developer of MM-1, Prof. Dr. Ahmed Shafik.

MM-1 has been listed in the USA Patent Office, since a USA Patent was applied for in 1989. A Continuation MM-1 Patent Application Review was applied for August 1992, and April 1994, and the MM-1 is still pending USA Patent Approval!

MM-1 is listed in the AmFAR HIV/AIDS Treatment Directory Vol. 2, No. 4, Feb. 1989, Vol. 6, No. 1, Sept. 30, 1992 and Vol. 7, No. 4 Jan.10, 1995, The International Directory of HIV Clinical Trials (by The Canadian HIV Trials Network), June, 1992, pages 78 & 79, and AIDS Treatment News, issue #57, May 20, 1988 and issue #189, Dec.17, 1993.

MM-1 is a code name of a product proved to have immunopotentiating properties. It is an in vivo stimulator of natural killer cells, macrophage-mediated cytotoxicity and B cell response.

MM-1 is an Antiviral and Immunopotentiating drug which has very low toxicity and a wide safety margin. It appears that MM-1 penetrates and destroys the virus cover, thus preventing its adsorption to cell membrane.

The MM-1 drug restores the underlying Immunodeficiency in AIDS patients to within normal levels, opportunistic infections improved during MM-1 therapy, with the exception of Kaposi Sarcoma (KS), which is not affected by the drug.

The Patients were able to return to their work and normal activities of living after treatment with MM-1, thus allowing Persons with HIV/AIDS, and their families to live out their lives in peace, comfort and dignity!

Perhaps you may be interested, and perhaps you may even be willing to assist us as well.

Would you be willing to Volunteer and assist us in getting HIV Groups, Agencies and Organizations, Medical and Pharmaceutical Institutions, Universities and the Medical and Scientific Communities aware, informed and interested in MM-1, so that they can Sponsor the MM-1 Clinical Trials, in order to assist those Persons with HIV/AIDS to obtain FREE Medical Treatment with The MM-1 (FREE of CHARGE), IF they qualify for the Clinical Trials Study? If so, then please give details. Thank You very much.

Regards, MICA, INC.




Post Extras: Remind Me!   Notify Moderator  
Pages: 1

What's New at

Additional Information
0 registered and 1 anonymous users are browsing this forum.

Moderator:  TheBody, bogart, gigi, riverprincess 

      You cannot start new topics
      You cannot reply to topics
      HTML is enabled
      UBBCode is enabled

Thread views: 1714

Jump to

Contact Us | Privacy Statement The Body

UBB.threads™ 6.2.3